|
|
| G
|
Abcb11
|
ATP binding cassette subfamily B member 11
|
increases expression
|
ISO
|
procymidone results in increased expression of ABCB11 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581
|
|
| G
|
Abcb4
|
ATP binding cassette subfamily B member 4
|
increases expression
|
EXP
|
procymidone results in increased expression of ABCB4 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 4:26,106,895...26,164,440
|
|
| G
|
Abcc2
|
ATP binding cassette subfamily C member 2
|
increases expression
|
ISO
|
procymidone results in increased expression of ABCC2 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
|
|
| G
|
Acly
|
ATP citrate lyase
|
multiple interactions decreases expression increases expression
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of ACLY mRNA procymidone results in decreased expression of ACLY mRNA procymidone results in increased expression of ACLY mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631
|
|
| G
|
Acot1
|
acyl-CoA thioesterase 1
|
multiple interactions decreases expression increases expression
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of ACOT1 mRNA procymidone results in decreased expression of ACOT1 mRNA procymidone results in increased expression of ACOT1 mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:109,367,268...109,380,749
|
|
| G
|
Acox1
|
acyl-CoA oxidase 1
|
multiple interactions decreases expression increases expression
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of ACOX1 mRNA procymidone results in decreased expression of ACOX1 mRNA procymidone results in increased expression of ACOX1 mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136
|
|
| G
|
Actn1
|
actinin, alpha 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ACTN1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:104,731,485...104,826,172
|
|
| G
|
Acvr2b
|
activin A receptor type 2B
|
decreases expression
|
EXP
|
procymidone results in decreased expression of SCGB2A2 mRNA
|
CTD |
PMID:15590119 |
|
NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:128,016,526...128,048,171
|
|
| G
|
Adh4
|
alcohol dehydrogenase 4 (class II), pi polypeptide
|
increases expression
|
EXP
|
procymidone results in increased expression of ADH4 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 2:229,622,092...229,640,120
Ensembl chr 2:229,622,095...229,641,879
|
|
| G
|
Ak3
|
adenylate kinase 3
|
increases expression
|
EXP
|
procymidone results in increased expression of AK3 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 1:236,151,012...236,178,689
Ensembl chr 1:236,151,012...236,178,183
|
|
| G
|
Amh
|
anti-Mullerian hormone
|
multiple interactions
|
EXP
|
[Diethylhexyl Phthalate co-treated with procymidone] results in decreased expression of AMH mRNA
|
CTD |
PMID:34051340 |
|
NCBI chr 7:9,557,451...9,559,867
Ensembl chr 7:9,557,451...9,559,867
|
|
| G
|
Angpt4
|
angiopoietin 4
|
increases expression multiple interactions
|
ISO
|
procymidone results in increased expression of ANGPT4 mRNA [tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of ANGPT4 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 3:160,880,539...160,913,923
Ensembl chr 3:160,880,728...160,913,921
|
|
| G
|
Ano1
|
anoctamin 1
|
affects expression
|
ISO
|
procymidone affects the expression of ANO1 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 1:209,180,755...209,329,413
Ensembl chr 1:209,180,755...209,329,550
|
|
| G
|
Apex1
|
apurinic/apyrimidinic endodeoxyribonuclease 1
|
increases expression
|
EXP
|
procymidone results in increased expression of APEX1 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329
|
|
| G
|
Ar
|
androgen receptor
|
multiple interactions decreases activity affects binding increases expression decreases expression
|
EXP ISO
|
procymidone binds to and results in decreased activity of AR protein procymidone results in decreased activity of AR protein procymidone binds to AR protein procymidone results in increased expression of AR mRNA [procymidone co-treated with prochloraz co-treated with vinclozolin] inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; [procymidone co-treated with vinclozolin] inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; Dihydrotestosterone inhibits the reaction [procymidone results in increased activity of AR protein]; procymidone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; procymidone inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; procymidone inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]; procymidone inhibits the reaction [Metribolone binds to and results in increased activity of AR protein]; procymidone inhibits the reaction [Metribolone binds to AR protein]; procymidone inhibits the reaction [Metribolone results in increased activity of AR protein] procymidone results in decreased expression of AR mRNA
|
CTD |
PMID:10053169 PMID:10188193 PMID:14565775 PMID:15064155 PMID:15589981 PMID:15686871 PMID:18315717 PMID:18324785 PMID:20821581 PMID:21310686 PMID:26602169 PMID:33049310 PMID:35913088 More...
|
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Asic3
|
acid sensing ion channel subunit 3
|
decreases expression
|
EXP
|
procymidone results in decreased expression of ASIC3 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 4:11,652,946...11,657,415
Ensembl chr 4:11,652,946...11,657,367
|
|
| G
|
Atf4
|
activating transcription factor 4
|
increases expression
|
ISO
|
procymidone results in increased expression of ATF4 mRNA
|
CTD |
PMID:35913088 |
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
|
|
| G
|
Atf6
|
activating transcription factor 6
|
increases expression
|
ISO
|
procymidone results in increased expression of ATF6 mRNA; procymidone results in increased expression of ATF6 protein
|
CTD |
PMID:35913088 |
|
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
|
|
| G
|
Atp2a2
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
|
decreases expression
|
EXP
|
procymidone results in decreased expression of ATP2A2 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934
|
|
| G
|
Atp5f1b
|
ATP synthase F1 subunit beta
|
decreases expression
|
ISO
|
procymidone results in decreased expression of ATP5B mRNA
|
CTD |
PMID:35913088 |
|
NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:1,099,860...1,106,462
|
|
| G
|
Bace1
|
beta-secretase 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BACE1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:55,038,823...55,064,918
|
|
| G
|
Bace2
|
beta-secretase 2
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr11:50,176,852...50,258,948
Ensembl chr11:50,176,621...50,259,008
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression
|
EXP ISO
|
procymidone results in increased expression of BAX mRNA
|
CTD |
PMID:15686871 PMID:33413771 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bckdk
|
branched chain ketoacid dehydrogenase kinase
|
decreases expression
|
EXP
|
procymidone results in decreased expression of BCKDK mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 1:191,945,809...191,950,480
Ensembl chr 1:191,946,471...191,953,453
|
|
| G
|
Bdnf
|
brain-derived neurotrophic factor
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BDNF mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
| G
|
Bsn
|
bassoon (presynaptic cytomatrix protein)
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BSN mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 8:117,663,447...117,754,412
Ensembl chr 8:117,670,334...117,754,412
|
|
| G
|
C3
|
complement C3
|
increases expression multiple interactions
|
EXP
|
procymidone results in increased expression of C3 mRNA [vinclozolin co-treated with procymidone co-treated with Flutamide] results in increased expression of C3 mRNA
|
CTD |
PMID:17420220 |
|
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
|
|
| G
|
Cacna1a
|
calcium voltage-gated channel subunit alpha1 A
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1A mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr19:40,425,560...40,724,810
Ensembl chr19:40,425,560...40,724,599
|
|
| G
|
Cacna1b
|
calcium voltage-gated channel subunit alpha1 B
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1B mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 3:27,779,133...27,944,292
Ensembl chr 3:27,779,166...27,944,285
|
|
| G
|
Cacna1c
|
calcium voltage-gated channel subunit alpha1 C
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1C mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:153,436,427...154,051,762
|
|
| G
|
Cacna1d
|
calcium voltage-gated channel subunit alpha1 D
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1D mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr16:5,233,682...5,527,549
Ensembl chr16:5,233,690...5,674,692
|
|
| G
|
Cacna1g
|
calcium voltage-gated channel subunit alpha1 G
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1G mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,851,896...79,919,634
|
|
| G
|
Cacna1i
|
calcium voltage-gated channel subunit alpha1 I
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNA1I mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 7:113,716,266...113,827,670
Ensembl chr 7:113,716,266...113,827,670
|
|
| G
|
Cacna2d3
|
calcium voltage-gated channel auxiliary subunit alpha2delta 3
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CACNA2D3 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr16:4,105,048...4,919,037
Ensembl chr16:4,105,048...4,919,098
|
|
| G
|
Cacnb1
|
calcium voltage-gated channel auxiliary subunit beta 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr10:83,494,509...83,515,164
Ensembl chr10:83,494,509...83,515,146
|
|
| G
|
Cacnb3
|
calcium voltage-gated channel auxiliary subunit beta 3
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB3 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 7:131,663,810...131,676,085
Ensembl chr 7:131,662,545...131,676,085
|
|
| G
|
Cacng2
|
calcium voltage-gated channel auxiliary subunit gamma 2
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG2 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 7:111,451,605...111,579,071
Ensembl chr 7:111,455,006...111,577,757
|
|
| G
|
Cacng6
|
calcium voltage-gated channel auxiliary subunit gamma 6
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG6 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 1:74,648,342...74,663,351
Ensembl chr 1:74,648,063...74,662,753
|
|
| G
|
Cacng7
|
calcium voltage-gated channel auxiliary subunit gamma 7
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNG7 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 1:74,715,483...74,746,669
Ensembl chr 1:74,715,483...74,746,669
|
|
| G
|
Cadm1
|
cell adhesion molecule 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CADM1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 8:56,744,374...57,075,264
Ensembl chr 8:56,744,372...57,080,192
|
|
| G
|
Calr
|
calreticulin
|
decreases expression
|
EXP
|
procymidone results in decreased expression of CALR mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236
|
|
| G
|
Camk2b
|
calcium/calmodulin-dependent protein kinase II beta
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CAMK2B mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr14:85,059,166...85,148,121
Ensembl chr14:85,059,191...85,148,485
|
|
| G
|
Camk2g
|
calcium/calmodulin-dependent protein kinase II gamma
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CAMK2G mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr15:3,553,238...3,612,310
Ensembl chr15:3,553,294...3,612,310
|
|
| G
|
Casp12
|
caspase 12
|
increases expression
|
ISO
|
procymidone results in increased expression of CASP12; procymidone results in increased expression of CASP12 mRNA
|
CTD |
PMID:33413771 PMID:35913088 |
|
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442
|
|
| G
|
Casp3
|
caspase 3
|
increases expression
|
ISO
|
procymidone results in increased expression of CASP3; procymidone results in increased expression of CASP3 mRNA
|
CTD |
PMID:33413771 PMID:35913088 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp9
|
caspase 9
|
increases expression
|
ISO
|
procymidone results in increased expression of CASP9; procymidone results in increased expression of CASP9 mRNA
|
CTD |
PMID:33413771 PMID:35913088 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Ccnd1
|
cyclin D1
|
decreases expression
|
EXP
|
procymidone results in decreased expression of CCND1 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccne1
|
cyclin E1
|
increases expression
|
EXP
|
procymidone results in increased expression of CCNE1 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822
|
|
| G
|
Cd44
|
CD44 molecule
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CD44 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424
|
|
| G
|
Cd81
|
Cd81 molecule
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CD81 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 1:207,665,274...207,681,094
Ensembl chr 1:207,664,885...207,681,092
|
|
| G
|
Cdh1
|
cadherin 1
|
multiple interactions
|
ISO
|
[procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin co-treated with 4-hydroxy-2-nonenal] results in decreased expression of CDH1 protein; [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in decreased expression of CDH1 protein
|
CTD |
PMID:34503147 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
| G
|
Cftr
|
CF transmembrane conductance regulator
|
decreases expression multiple interactions increases expression affects expression
|
ISO
|
procymidone results in decreased expression of CFTR protein [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of CFTR protein; [tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of CFTR mRNA procymidone results in increased expression of CFTR mRNA procymidone affects the expression of CFTR mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:47,526,735...47,694,643
|
|
| G
|
Chga
|
chromogranin A
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CHGA mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 6:127,460,895...127,472,238
Ensembl chr 6:127,460,854...127,472,237
|
|
| G
|
Cldn1
|
claudin 1
|
decreases expression
|
ISO
|
procymidone results in decreased expression of CLDN1 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529
|
|
| G
|
Clu
|
clusterin
|
increases expression multiple interactions
|
EXP
|
procymidone results in increased expression of CLU mRNA [vinclozolin co-treated with procymidone] results in increased expression of CLU mRNA
|
CTD |
PMID:12563111 PMID:15590119 |
|
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860
|
|
| G
|
Cpd
|
carboxypeptidase D
|
increases expression
|
EXP
|
procymidone results in increased expression of CPD mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr10:62,121,681...62,185,638
Ensembl chr10:62,121,679...62,185,638
|
|
| G
|
Cpt1a
|
carnitine palmitoyltransferase 1A
|
decreases expression multiple interactions increases expression
|
ISO
|
procymidone results in decreased expression of CPT1A mRNA [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of CPT1A mRNA procymidone results in increased expression of CPT1A mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326
|
|
| G
|
Crhr2
|
corticotropin releasing hormone receptor 2
|
decreases expression
|
EXP
|
procymidone results in decreased expression of CRHR2 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 4:85,553,163...85,596,203
Ensembl chr 4:85,554,268...85,596,318
|
|
| G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
decreases expression
|
EXP
|
procymidone results in decreased expression of CXCL10 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
decreases expression
|
EXP
|
procymidone results in decreased expression of CXCL2 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Cyp11a1
|
cytochrome P450, family 11, subfamily a, polypeptide 1
|
increases expression decreases expression
|
EXP ISO
|
procymidone results in increased expression of CYP11A1 mRNA procymidone results in decreased expression of CYP11A1 mRNA
|
CTD |
PMID:15686871 PMID:35913088 |
|
NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196
|
|
| G
|
Cyp19a1
|
cytochrome P450, family 19, subfamily a, polypeptide 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP19A1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
|
|
| G
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1
|
affects expression
|
ISO
|
procymidone affects the expression of CYP27A1 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215
|
|
| G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
multiple interactions increases expression
|
ISO
|
procymidone results in increased expression of and results in increased activity of CYP2E1 protein procymidone results in increased expression of CYP2E1 mRNA
|
CTD |
PMID:12787915 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
multiple interactions
|
ISO
|
[procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in increased expression of CYP3A4 mRNA
|
CTD |
PMID:25028461 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Cyp7a1
|
cytochrome P450 family 7 subfamily A member 1
|
affects expression
|
ISO
|
procymidone affects the expression of CYP7A1 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
|
|
| G
|
Dad1
|
defender against cell death 1
|
decreases expression
|
EXP
|
procymidone results in decreased expression of DAD1 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr15:31,647,326...31,667,159
Ensembl chr15:31,647,326...31,667,287
|
|
| G
|
Dbh
|
dopamine beta-hydroxylase
|
increases expression
|
EXP
|
procymidone results in increased expression of DBH mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 3:30,886,313...30,903,313
Ensembl chr 3:30,886,328...30,903,316
|
|
| G
|
Dbi
|
diazepam binding inhibitor
|
decreases expression
|
EXP
|
procymidone results in decreased expression of DBI mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr13:33,794,231...33,802,632
Ensembl chr13:33,759,845...33,821,450
|
|
| G
|
Dcc
|
DCC netrin 1 receptor
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DCC mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr18:67,144,272...68,248,159
Ensembl chr18:67,149,179...68,247,541
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
increases expression
|
ISO
|
procymidone results in increased expression of DDIT3 mRNA
|
CTD |
PMID:35913088 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Defa5
|
defensin alpha 5
|
multiple interactions affects expression
|
ISO
|
[tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of DEFA5 mRNA procymidone affects the expression of DEFA5 mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr16:77,044,994...77,047,318
Ensembl chr16:77,044,994...77,047,318
|
|
| G
|
Dgat1
|
diacylglycerol O-acyltransferase 1
|
decreases expression multiple interactions increases expression
|
ISO
|
procymidone results in decreased expression of DGAT1 mRNA [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of DGAT1 mRNA procymidone results in increased expression of DGAT1 mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr 7:110,104,514...110,119,091
Ensembl chr 7:110,098,906...110,115,016
|
|
| G
|
Dgat2
|
diacylglycerol O-acyltransferase 2
|
multiple interactions decreases expression increases expression
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of DGAT2 mRNA procymidone results in decreased expression of DGAT2 mRNA procymidone results in increased expression of DGAT2 mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:162,866,237...162,896,566
|
|
| G
|
Dlg1
|
discs large MAGUK scaffold protein 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DLG1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr11:82,416,853...82,607,797
Ensembl chr11:82,416,853...82,607,797
|
|
| G
|
Dlg4
|
discs large MAGUK scaffold protein 4
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of DLG4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLG4 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr10:55,239,397...55,267,780
Ensembl chr10:55,236,869...55,265,839
|
|
| G
|
Dlgap3
|
DLG associated protein 3
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP3 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 5:144,776,414...144,847,097
Ensembl chr 5:144,777,295...144,847,097
|
|
| G
|
Dlgap4
|
DLG associated protein 4
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP4 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 3:165,584,271...165,731,868
Ensembl chr 3:165,584,360...165,730,604
|
|
| G
|
Dnaja1
|
DnaJ heat shock protein family (Hsp40) member A1
|
decreases expression
|
EXP
|
procymidone results in decreased expression of DNAJA1 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 5:60,638,404...60,649,315
Ensembl chr 5:60,638,410...60,650,160
|
|
| G
|
Doc2a
|
double C2 domain alpha
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DOC2A mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 1:190,887,306...190,893,057
Ensembl chr 1:190,888,214...190,893,384
|
|
| G
|
Dpp10
|
dipeptidyl peptidase like 10
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPP10 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr13:37,145,531...38,821,987
Ensembl chr13:37,145,531...38,822,801
|
|
| G
|
Dpp6
|
dipeptidyl peptidase like 6
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DPP6 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 4:8,323,220...9,242,694
Ensembl chr 4:8,324,843...9,242,209
|
|
| G
|
Dpyd
|
dihydropyrimidine dehydrogenase
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPYD mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 2:209,293,902...210,159,777
Ensembl chr 2:209,293,929...210,159,778
|
|
| G
|
Drd1
|
dopamine receptor D1
|
increases expression
|
EXP
|
procymidone results in increased expression of DRD1 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,545,111...10,567,166
|
|
| G
|
Egf
|
epidermal growth factor
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGF mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297
|
|
| G
|
Egfr
|
epidermal growth factor receptor
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGFR mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
| G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
increases expression
|
ISO
|
procymidone results in increased expression of EIF2AK3 mRNA; procymidone results in increased expression of EIF2AK3 protein
|
CTD |
PMID:35913088 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
|
|
| G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
increases expression
|
ISO
|
procymidone results in increased expression of EIF2S1 mRNA
|
CTD |
PMID:35913088 |
|
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
|
|
| G
|
Erbb2
|
erb-b2 receptor tyrosine kinase 2
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB2 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481
|
|
| G
|
Erbb3
|
erb-b2 receptor tyrosine kinase 3
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB3 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:1,579,816...1,601,120
|
|
| G
|
Erbb4
|
erb-b2 receptor tyrosine kinase 4
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB4 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 9:76,973,386...78,045,633
Ensembl chr 9:76,973,227...78,045,772
|
|
| G
|
Ern1
|
endoplasmic reticulum to nucleus signaling 1
|
increases expression
|
ISO
|
procymidone results in increased expression of ERN1 mRNA; procymidone results in increased expression of ERN1 protein
|
CTD |
PMID:35913088 |
|
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791
|
|
| G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
ISO
|
procymidone binds to and results in increased activity of ESR1 protein
|
CTD |
PMID:33049310 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esr2
|
estrogen receptor 2
|
multiple interactions
|
ISO
|
procymidone binds to and results in increased activity of ESR2 protein
|
CTD |
PMID:33049310 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
Fabp1
|
fatty acid binding protein 1
|
multiple interactions decreases expression increases expression
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of FABP1 mRNA procymidone results in decreased expression of FABP1 mRNA procymidone results in increased expression of FABP1 mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:104,744,309...104,753,113
|
|
| G
|
Fabp6
|
fatty acid binding protein 6
|
affects expression
|
ISO
|
procymidone affects the expression of FABP6 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr10:28,565,054...28,569,727
Ensembl chr10:28,565,054...28,573,058
|
|
| G
|
Fasn
|
fatty acid synthase
|
multiple interactions decreases expression increases expression
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of FASN mRNA procymidone results in decreased expression of FASN mRNA procymidone results in increased expression of FASN mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
| G
|
Fgf19
|
fibroblast growth factor 19
|
affects expression
|
ISO
|
procymidone affects the expression of FGF15 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 1:209,485,813...209,490,267
Ensembl chr 1:209,485,813...209,490,267
|
|
| G
|
Fmr1
|
fragile X messenger ribonucleoprotein 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FMR1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr X:152,284,857...152,322,686
Ensembl chr X:152,284,841...152,322,675
|
|
| G
|
Fshb
|
follicle stimulating hormone subunit beta
|
increases expression multiple interactions
|
EXP
|
procymidone results in increased expression of FSHB protein [vinclozolin co-treated with procymidone] results in increased expression of FSHB protein
|
CTD |
PMID:12563111 |
|
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072
|
|
| G
|
Fyn
|
FYN proto-oncogene, Src family tyrosine kinase
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FYN mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr20:44,322,635...44,514,498
Ensembl chr20:44,322,361...44,515,479
|
|
| G
|
Gabra4
|
gamma-aminobutyric acid type A receptor subunit alpha 4
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRA4 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr14:36,944,747...37,021,652
Ensembl chr14:36,944,388...37,021,648
|
|
| G
|
Gabrb1
|
gamma-aminobutyric acid type A receptor subunit beta1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRB1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr14:36,434,339...36,917,920
Ensembl chr14:36,434,352...36,902,893
|
|
| G
|
Gck
|
glucokinase
|
multiple interactions decreases expression affects expression
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of GCK mRNA procymidone results in decreased expression of GCK mRNA procymidone affects the expression of GCK mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949
|
|
| G
|
Gdnf
|
glial cell derived neurotrophic factor
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GDNF mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:58,621,327...58,647,240
|
|
| G
|
Gls
|
glutaminase
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GLS mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 9:56,836,584...56,908,861
Ensembl chr 9:56,836,584...56,908,861
|
|
| G
|
Gng5
|
G protein subunit gamma 5
|
decreases expression
|
EXP
|
procymidone results in decreased expression of GNG5 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 2:238,054,954...238,063,451
Ensembl chr11:58,096,362...58,096,565 Ensembl chr 2:58,096,362...58,096,565
|
|
| G
|
Gnrh1
|
gonadotropin releasing hormone 1
|
decreases expression
|
EXP
|
procymidone results in decreased expression of GNRH1 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr15:46,147,878...46,152,086
Ensembl chr15:46,148,301...46,148,977 Ensembl chr15:46,148,301...46,148,977
|
|
| G
|
Gpam
|
glycerol-3-phosphate acyltransferase, mitochondrial
|
decreases expression multiple interactions increases expression
|
ISO
|
procymidone results in decreased expression of GPAM mRNA [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of GPAM mRNA procymidone results in increased expression of GPAM mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr 1:264,111,599...264,176,112
Ensembl chr 1:264,113,813...264,175,911
|
|
| G
|
Gria2
|
glutamate ionotropic receptor AMPA type subunit 2
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA2 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616
|
|
| G
|
Gria4
|
glutamate ionotropic receptor AMPA type subunit 4
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA4 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 8:9,845,421...10,320,021
Ensembl chr 8:9,847,052...10,319,881
|
|
| G
|
Grik1
|
glutamate ionotropic receptor kainate type subunit 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIK1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr11:40,655,974...41,056,966
Ensembl chr11:40,655,975...41,056,517
|
|
| G
|
Grik2
|
glutamate ionotropic receptor kainate type subunit 2
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIK2 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr20:53,717,564...54,415,283
Ensembl chr20:53,716,090...54,415,202
|
|
| G
|
Grin1
|
glutamate ionotropic receptor NMDA type subunit 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:28,501,836...28,528,754
|
|
| G
|
Grin2b
|
glutamate ionotropic receptor NMDA type subunit 2B
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN2B mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570
|
|
| G
|
Grip1
|
glutamate receptor interacting protein 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIP1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 7:56,820,501...57,477,877
Ensembl chr 7:56,820,704...57,468,417
|
|
| G
|
H2ax
|
H2A.X variant histone
|
multiple interactions
|
ISO
|
[fludioxonil co-treated with cyprodinil co-treated with procymidone co-treated with iprodione co-treated with cyhalothrin] results in increased phosphorylation of H2AX protein; [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin co-treated with 4-hydroxy-2-nonenal] results in increased expression of H2AX protein; [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in increased expression of H2AX protein
|
CTD |
PMID:22389207 PMID:34503147 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
Hes6
|
hes family bHLH transcription factor 6
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of HES6 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 9:99,449,375...99,451,343
Ensembl chr 9:99,449,371...99,451,096
|
|
| G
|
Hnf4a
|
hepatocyte nuclear factor 4, alpha
|
decreases expression
|
EXP
|
procymidone results in decreased expression of HNF4A mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 3:172,606,220...172,667,758
Ensembl chr 3:172,606,220...172,667,758
|
|
| G
|
Hoxa4
|
homeo box A4
|
decreases expression
|
EXP
|
procymidone results in decreased expression of HOXA4 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 4:82,620,294...82,622,302
Ensembl chr 4:82,620,299...82,622,302
|
|
| G
|
Hsd17b1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
decreases expression
|
ISO
|
procymidone results in decreased expression of HSD17B1 mRNA
|
CTD |
PMID:35913088 |
|
NCBI chr10:86,510,011...86,512,211
Ensembl chr10:86,510,011...86,512,210
|
|
| G
|
Hsp90b1
|
heat shock protein 90 beta family member 1
|
decreases expression
|
EXP
|
procymidone results in decreased expression of HSP90B1 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:22,997,962...23,012,293
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
decreases expression increases expression
|
EXP ISO
|
procymidone results in decreased expression of HSPA5 mRNA procymidone results in increased expression of HSPA5 mRNA; procymidone results in increased expression of HSPA5 protein
|
CTD |
PMID:15686871 PMID:35913088 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Htt
|
huntingtin
|
decreases expression
|
EXP
|
procymidone results in decreased expression of HTT mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr14:80,070,456...80,219,668
Ensembl chr14:80,070,456...80,219,668
|
|
| G
|
Hyou1
|
hypoxia up-regulated 1
|
decreases expression
|
EXP
|
procymidone results in decreased expression of HYOU1 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 8:53,602,882...53,614,998
Ensembl chr 8:53,602,604...53,614,997
|
|
| G
|
Ifng
|
interferon gamma
|
affects expression
|
ISO
|
procymidone affects the expression of IFNG mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Igf2r
|
insulin-like growth factor 2 receptor
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of IGF2R mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 1:50,526,878...50,615,265
Ensembl chr 1:50,526,878...50,615,265
|
|
| G
|
Il17a
|
interleukin 17A
|
affects expression increases expression
|
ISO
|
procymidone affects the expression of IL17A protein procymidone results in increased expression of IL17A mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
|
|
| G
|
Il1b
|
interleukin 1 beta
|
affects expression
|
ISO
|
procymidone affects the expression of IL1B mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1rapl1
|
interleukin 1 receptor accessory protein-like 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of IL1RAPL1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr X:55,322,779...56,827,486
Ensembl chr X:55,328,964...56,826,613
|
|
| G
|
Il6
|
interleukin 6
|
affects expression
|
ISO
|
procymidone affects the expression of IL6 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Ins1
|
insulin 1
|
multiple interactions decreases expression
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of INS1 protein procymidone results in decreased expression of INS1 protein
|
CTD |
PMID:33246813 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
|
|
| G
|
Klf4
|
KLF transcription factor 4
|
increases expression multiple interactions decreases expression
|
ISO
|
procymidone results in increased expression of KLF4 mRNA [tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of KLF4 mRNA procymidone results in decreased expression of KLF4 mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:75,074,236...75,078,592
|
|
| G
|
Klk1b3
|
kallikrein 1-related peptidase B3
|
decreases expression
|
EXP
|
procymidone results in decreased expression of KLK1B3 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 1:103,845,647...103,849,854
Ensembl chr 1:103,845,603...103,849,855
|
|
| G
|
Klk1c10
|
kallikrein 1-related peptidase C10
|
decreases expression
|
ISO
|
procymidone results in decreased expression of KLK3 mRNA
|
CTD |
PMID:33932781 |
|
NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:103,539,527...103,543,586
|
|
| G
|
Krt18
|
keratin 18
|
increases expression
|
EXP
|
procymidone results in increased expression of KRT18 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848 Ensembl chr10:135,035,982...135,039,848
|
|
| G
|
Lcn2
|
lipocalin 2
|
decreases expression
|
ISO
|
procymidone results in decreased expression of LCN2 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842
|
|
| G
|
Lhb
|
luteinizing hormone subunit beta
|
increases expression multiple interactions
|
EXP
|
procymidone results in increased expression of LHB protein [vinclozolin co-treated with procymidone] results in increased expression of LHB protein
|
CTD |
PMID:12563111 |
|
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445
|
|
| G
|
Lhx5
|
LIM homeobox 5
|
decreases expression
|
EXP
|
procymidone results in decreased expression of LHX5 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr12:41,786,746...41,795,183
Ensembl chr12:41,786,746...41,795,183
|
|
| G
|
Lrrc7
|
leucine rich repeat containing 7
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of LRRC7 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 2:249,792,441...250,294,267
Ensembl chr 2:249,805,448...250,293,718
|
|
| G
|
Lum
|
lumican
|
decreases expression
|
EXP
|
procymidone results in decreased expression of LUM mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:34,245,360...34,252,508
|
|
| G
|
Magi2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of MAGI2 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 4:15,278,518...16,762,427
Ensembl chr 4:15,278,518...16,762,199
|
|
| G
|
Map3k5
|
mitogen-activated protein kinase kinase kinase 5
|
increases expression
|
ISO
|
procymidone results in increased expression of MAP3K5 mRNA
|
CTD |
PMID:35913088 |
|
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
increases expression
|
EXP
|
procymidone results in increased expression of MAPK1 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk10
|
mitogen activated protein kinase 10
|
increases expression
|
ISO
|
procymidone results in increased expression of MAPK10 mRNA
|
CTD |
PMID:35913088 |
|
NCBI chr14:6,802,247...7,094,103
Ensembl chr14:6,802,295...7,094,100
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
increases expression
|
ISO
|
procymidone results in increased expression of MAPK8 mRNA
|
CTD |
PMID:35913088 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mapk9
|
mitogen-activated protein kinase 9
|
increases expression
|
ISO
|
procymidone results in increased expression of MAPK9 mRNA
|
CTD |
PMID:35913088 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
| G
|
Mbp
|
myelin basic protein
|
decreases expression
|
EXP
|
procymidone results in decreased expression of MBP mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr18:78,130,652...78,241,174
Ensembl chr18:78,130,325...78,241,174
|
|
| G
|
Mdga2
|
MAM domain containing glycosylphosphatidylinositol anchor 2
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of MDGA2 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 6:90,482,687...91,346,784
Ensembl chr 6:90,498,119...91,344,413
|
|
| G
|
Mdm2
|
MDM2 proto-oncogene
|
decreases expression
|
EXP
|
procymidone results in decreased expression of MDM2 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791
|
|
| G
|
Me1
|
malic enzyme 1
|
decreases expression
|
EXP
|
procymidone results in decreased expression of ME1 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275
|
|
| G
|
Mep1b
|
meprin A subunit beta
|
increases expression multiple interactions affects expression
|
ISO
|
procymidone results in increased expression of MEP1B mRNA [tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of MEP1B mRNA procymidone affects the expression of MEP1B mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr18:12,641,041...12,667,759
Ensembl chr18:12,641,041...12,667,755
|
|
| G
|
Mgp
|
matrix Gla protein
|
increases expression
|
EXP
|
procymidone results in increased expression of MGP mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:171,497,471...171,500,859
|
|
| G
|
Mir212
|
microRNA 212
|
increases expression
|
ISO
|
procymidone results in increased expression of MIR212 mRNA
|
CTD |
PMID:35913088 |
|
NCBI chr10:60,521,740...60,521,850
Ensembl chr10:60,521,740...60,521,850
|
|
| G
|
Mlxip
|
MLX interacting protein
|
multiple interactions
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in increased expression of MLXIP mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr12:38,789,404...38,853,059
Ensembl chr12:38,789,404...38,853,059
|
|
| G
|
Mmp7
|
matrix metallopeptidase 7
|
affects expression
|
ISO
|
procymidone affects the expression of MMP7 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:13,133,043...13,140,755
|
|
| G
|
Msmb
|
microseminoprotein, beta
|
decreases expression
|
ISO
|
procymidone results in decreased expression of MSMB mRNA
|
CTD |
PMID:33932781 |
|
NCBI chr16:7,372,803...7,393,406
Ensembl chr16:7,372,819...7,393,405
|
|
| G
|
Mttp
|
microsomal triglyceride transfer protein
|
decreases expression multiple interactions increases expression
|
ISO
|
procymidone results in decreased expression of MTTP mRNA [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of MTTP mRNA procymidone results in increased expression of MTTP mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr 2:229,286,501...229,327,650
Ensembl chr 2:229,286,501...229,327,650
|
|
| G
|
Muc1
|
mucin 1, cell surface associated
|
affects expression
|
ISO
|
procymidone affects the expression of MUC1 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:176,933,047...176,938,491
|
|
| G
|
Muc17
|
mucin 17, cell surface associated
|
multiple interactions decreases expression increases expression
|
ISO
|
[tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of MUC17 mRNA procymidone results in decreased expression of MUC17 mRNA procymidone results in increased expression of MUC17 mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr12:25,139,076...25,175,249
|
|
| G
|
Muc2
|
mucin 2, oligomeric mucus/gel-forming
|
decreases expression multiple interactions
|
ISO
|
procymidone results in decreased expression of MUC2 mRNA; procymidone results in decreased expression of MUC2 protein [tetrachloroisophthalonitrile co-treated with procymidone] results in decreased expression of MUC2 protein
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr 1:206,225,775...206,261,280
Ensembl chr 1:206,229,035...206,261,280
|
|
| G
|
Nat2
|
N-acetyltransferase 2
|
increases expression
|
EXP
|
procymidone results in increased expression of NAT2 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr16:26,974,874...27,005,191
Ensembl chr16:26,974,601...26,976,304
|
|
| G
|
Ncan
|
neurocan
|
increases expression
|
EXP
|
procymidone results in increased expression of NCAN mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr16:19,335,907...19,362,371
Ensembl chr16:19,335,907...19,362,371
|
|
| G
|
Nf1
|
neurofibromin 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NF1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr10:64,803,986...65,037,086
Ensembl chr10:64,804,266...65,034,946
|
|
| G
|
Nfix
|
nuclear factor I X
|
increases expression
|
EXP
|
procymidone results in increased expression of NFIX mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr19:40,259,873...40,356,966
Ensembl chr19:40,260,084...40,353,092
|
|
| G
|
Ngf
|
nerve growth factor
|
decreases expression
|
EXP
|
procymidone results in decreased expression of NGF mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
|
|
| G
|
Nlgn1
|
neuroligin 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NLGN1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 2:110,184,987...111,110,316
Ensembl chr 2:110,186,573...110,909,984
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
decreases expression
|
EXP
|
procymidone results in decreased expression of NOS3 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Notch2
|
notch receptor 2
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of NOTCH2 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 2:188,299,336...188,432,823
Ensembl chr 2:188,299,336...188,432,823
|
|
| G
|
Notch3
|
notch receptor 3
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NOTCH3 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 7:11,783,550...11,834,585
Ensembl chr 7:11,784,272...11,834,778
|
|
| G
|
Notch4
|
notch receptor 4
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NOTCH4 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr20:4,164,969...4,189,072
Ensembl chr20:4,161,730...4,189,072
|
|
| G
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4
|
increases expression
|
ISO
|
procymidone results in increased expression of NR1H4 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:25,733,471...25,829,389
|
|
| G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
multiple interactions
|
ISO
|
[procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in increased activity of NR1I2 protein; procymidone binds to and results in increased activity of NR1I2 protein
|
CTD |
PMID:21115097 PMID:25028461 PMID:33049310 |
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
|
|
| G
|
Nr2f6
|
nuclear receptor subfamily 2, group F, member 6
|
increases expression
|
EXP
|
procymidone results in increased expression of NR2F6 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr16:18,080,003...18,087,449
Ensembl chr16:18,080,003...18,087,449
|
|
| G
|
Nrcam
|
neuronal cell adhesion molecule
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRCAM mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 6:67,129,723...67,425,510
Ensembl chr 6:67,129,801...67,430,539
|
|
| G
|
Nrg1
|
neuregulin 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849
|
|
| G
|
Nrp2
|
neuropilin 2
|
decreases expression
|
EXP
|
procymidone results in decreased expression of NRP2 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 9:71,616,602...71,731,869
Ensembl chr 9:71,616,657...71,731,871
|
|
| G
|
Nrxn1
|
neurexin 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRXN1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 6:8,931,360...10,077,381
Ensembl chr 6:8,935,523...10,077,374
|
|
| G
|
Nrxn2
|
neurexin 2
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRXN2 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 1:213,155,673...213,271,526
Ensembl chr 1:213,155,673...213,271,526
|
|
| G
|
Ntrk2
|
neurotrophic receptor tyrosine kinase 2
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NTRK2 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,564,570...5,874,628
|
|
| G
|
Ocel1
|
occludin/ELL domain containing 1
|
decreases expression
|
ISO
|
procymidone results in decreased expression of OCEL1 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr16:18,076,428...18,079,068
Ensembl chr16:18,077,266...18,079,374
|
|
| G
|
Odc1
|
ornithine decarboxylase 1
|
decreases expression multiple interactions
|
EXP
|
procymidone results in decreased expression of ODC1 mRNA [vinclozolin co-treated with procymidone co-treated with Flutamide] results in decreased expression of ODC1 mRNA
|
CTD |
PMID:17420220 |
|
NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146
|
|
| G
|
P4hb
|
prolyl 4-hydroxylase subunit beta
|
decreases expression
|
EXP
|
procymidone results in decreased expression of P4HB mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr10:106,335,300...106,346,911
Ensembl chr10:106,335,300...106,346,911
|
|
| G
|
Pdcd2
|
programmed cell death 2
|
increases expression
|
EXP
|
procymidone results in increased expression of PDCD2 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 1:65,158,034...65,163,524
Ensembl chr 1:65,158,034...65,163,524
|
|
| G
|
Pdia3
|
protein disulfide isomerase family A, member 3
|
decreases expression
|
EXP
|
procymidone results in decreased expression of PDIA3 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:128,841,917...128,867,327
|
|
| G
|
Pdia4
|
protein disulfide isomerase family A, member 4
|
decreases expression
|
EXP
|
procymidone results in decreased expression of PDIA4 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 4:78,134,144...78,153,191
Ensembl chr 4:78,134,144...78,153,191
|
|
| G
|
Pgr
|
progesterone receptor
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of PGR mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271
|
|
| G
|
Pgrmc1
|
progesterone receptor membrane component 1
|
decreases expression
|
EXP
|
procymidone results in decreased expression of PGRMC1 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr X:120,698,610...120,706,805
Ensembl chr X:120,698,610...120,706,805
|
|
| G
|
Pip
|
prolactin induced protein
|
decreases expression
|
EXP
|
procymidone results in decreased expression of PIP mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 4:71,754,265...71,758,559
Ensembl chr 4:71,754,265...71,758,559
|
|
| G
|
Pklr
|
pyruvate kinase L/R
|
decreases expression multiple interactions increases expression
|
ISO
|
procymidone results in decreased expression of PKLR mRNA [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of PKLR mRNA procymidone results in increased expression of PKLR mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr 2:176,840,779...176,849,637
Ensembl chr 2:176,840,764...176,849,644
|
|
| G
|
Pla2g4a
|
phospholipase A2 group 4A
|
increases expression multiple interactions affects expression
|
ISO
|
procymidone results in increased expression of PLA2G4A mRNA [tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of PLA2G4A mRNA procymidone affects the expression of PLA2G4A mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641
|
|
| G
|
Plat
|
plasminogen activator, tissue type
|
decreases expression
|
EXP
|
procymidone results in decreased expression of PLAT mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696
|
|
| G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
multiple interactions decreases expression increases expression
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of PPARA mRNA procymidone results in decreased expression of PPARA mRNA procymidone results in increased expression of PPARA mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
multiple interactions decreases expression affects expression
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of PPARG mRNA; procymidone binds to and results in increased activity of PPARG protein procymidone results in decreased expression of PPARG mRNA procymidone affects the expression of PPARG mRNA
|
CTD |
PMID:33049310 PMID:33246813 PMID:36764477 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Prdx1
|
peroxiredoxin 1
|
decreases expression
|
EXP
|
procymidone results in decreased expression of PRDX1 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:135,383,906...135,399,504
|
|
| G
|
Prkar1a
|
protein kinase cAMP-dependent type I regulatory subunit alpha
|
decreases expression
|
EXP
|
procymidone results in decreased expression of PRKAR1A mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr10:95,120,537...95,139,028
Ensembl chr10:95,120,487...95,139,025
|
|
| G
|
Prkn
|
parkin RBR E3 ubiquitin protein ligase
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of PRKN mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:51,210,330...52,430,304
|
|
| G
|
Pten
|
phosphatase and tensin homolog
|
increases expression
|
EXP
|
procymidone results in increased expression of PTEN mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330
|
|
| G
|
Rbl2
|
RB transcriptional corepressor like 2
|
increases expression
|
EXP
|
procymidone results in increased expression of RBL2 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr19:32,049,690...32,096,467
Ensembl chr19:32,049,691...32,096,411
|
|
| G
|
Reg3g
|
regenerating family member 3 gamma
|
affects expression
|
ISO
|
procymidone affects the expression of REG3G mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 4:112,482,183...112,484,738
Ensembl chr 4:112,482,183...112,484,738
|
|
| G
|
Reln
|
reelin
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of RELN mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 4:13,628,440...14,055,201
Ensembl chr 4:13,628,399...14,055,162
|
|
| G
|
Retnlb
|
resistin like beta
|
affects expression
|
ISO
|
procymidone affects the expression of RETNLB mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr11:65,446,433...65,448,319
Ensembl chr11:65,446,434...65,448,319
|
|
| G
|
Robo1
|
roundabout guidance receptor 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ROBO1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr11:24,067,869...25,108,694
Ensembl chr11:24,067,878...25,108,694
|
|
| G
|
Rxra
|
retinoid X receptor alpha
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of RXRA mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:31,388,223...31,474,417
|
|
| G
|
Scd
|
stearoyl-CoA desaturase
|
multiple interactions decreases expression increases expression
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of SCD1 mRNA procymidone results in decreased expression of SCD1 mRNA procymidone results in increased expression of SCD1 mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785
|
|
| G
|
Shank2
|
SH3 and multiple ankyrin repeat domains 2
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SHANK2 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 1:208,575,144...209,020,300
Ensembl chr 1:208,598,772...209,018,736
|
|
| G
|
Slc10a2
|
solute carrier family 10 member 2
|
increases expression
|
ISO
|
procymidone results in increased expression of SLC10A2 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr16:91,088,089...91,111,025
Ensembl chr16:91,076,423...91,111,025
|
|
| G
|
Slc12a2
|
solute carrier family 12 member 2
|
increases expression multiple interactions affects expression
|
ISO
|
procymidone results in increased expression of SLC12A2 mRNA [tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of SLC12A2 mRNA procymidone affects the expression of SLC12A2 mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr18:53,546,263...53,614,478
Ensembl chr18:53,546,333...53,614,470
|
|
| G
|
Slc1a2
|
solute carrier family 1 member 2
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A2 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 3:109,460,109...109,590,445
Ensembl chr 3:109,459,630...109,605,249
|
|
| G
|
Slc1a6
|
solute carrier family 1 member 6
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A6 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 7:11,492,422...11,521,007
Ensembl chr 7:11,492,422...11,553,997
|
|
| G
|
Slc26a3
|
solute carrier family 26 member 3
|
multiple interactions affects expression
|
ISO
|
[tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of SLC26A3 mRNA procymidone affects the expression of SLC26A3 mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr 6:53,751,415...53,792,300
Ensembl chr 6:53,751,415...53,792,294
|
|
| G
|
Slc26a6
|
solute carrier family 26 member 6
|
affects expression
|
ISO
|
procymidone affects the expression of SLC26A6 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 8:118,438,110...118,448,271
Ensembl chr 8:118,438,180...118,448,270
|
|
| G
|
Slc27a2
|
solute carrier family 27 member 2
|
multiple interactions decreases expression affects expression
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of SLC27A2 mRNA procymidone results in decreased expression of SLC27A2 mRNA procymidone affects the expression of SLC27A2 mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr 3:134,258,101...134,295,581
Ensembl chr 3:134,258,101...134,295,581
|
|
| G
|
Slc2a2
|
solute carrier family 2 member 2
|
decreases expression affects expression
|
ISO
|
procymidone results in decreased expression of SLC2A2 mRNA procymidone affects the expression of SLC2A2 mRNA
|
CTD |
PMID:33246813 PMID:36764477 |
|
NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:113,537,972...113,568,467
|
|
| G
|
Slc51a
|
solute carrier family 51 member A
|
affects expression
|
ISO
|
procymidone affects the expression of SLC51A mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr11:81,804,141...81,818,539
Ensembl chr11:81,803,972...81,818,539
|
|
| G
|
Slc9a2
|
solute carrier family 9 member A2
|
affects expression
|
ISO
|
procymidone affects the expression of SLC9A2 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 9:50,427,612...50,510,043
Ensembl chr 9:50,426,798...50,510,040
|
|
| G
|
Slc9a3
|
solute carrier family 9 member A3
|
increases expression multiple interactions
|
ISO
|
procymidone results in increased expression of SLC9A3 mRNA [tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of SLC9A3 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 1:30,953,215...30,996,209
Ensembl chr 1:30,953,216...30,996,002
|
|
| G
|
Slco1a4
|
solute carrier organic anion transporter family, member 1a4
|
decreases expression
|
EXP
|
procymidone results in decreased expression of SLCO1A4 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 4:176,441,104...176,495,846
Ensembl chr 4:176,441,104...176,495,816
|
|
| G
|
Slit1
|
slit guidance ligand 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLIT1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 1:250,358,917...250,507,476
Ensembl chr 1:250,358,919...250,507,476
|
|
| G
|
Smad2
|
SMAD family member 2
|
decreases expression
|
EXP
|
procymidone results in decreased expression of SMAD2 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:72,124,863...72,187,388
|
|
| G
|
Sptbn2
|
spectrin, beta, non-erythrocytic 2
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SPTBN2 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 1:211,432,373...211,473,016
Ensembl chr 1:211,432,373...211,473,306
|
|
| G
|
Star
|
steroidogenic acute regulatory protein
|
decreases expression
|
ISO
|
procymidone results in decreased expression of STAR mRNA
|
CTD |
PMID:35913088 |
|
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447
|
|
| G
|
Stmn2
|
stathmin 2
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STMN2 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 2:95,112,017...95,159,642
Ensembl chr 2:95,112,019...95,159,335
|
|
| G
|
Sts
|
steroid sulfatase
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of STS mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr X:46,102,524...46,110,868
Ensembl chr X:46,102,548...46,111,104
|
|
| G
|
Stxbp1
|
syntaxin binding protein 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STXBP1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 3:36,474,428...36,536,120
Ensembl chr 3:36,474,428...36,536,058
|
|
| G
|
Sult1b1
|
sulfotransferase family 1B member 1
|
increases expression
|
EXP
|
procymidone results in increased expression of SULT1B1 mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr14:20,771,917...20,784,665
Ensembl chr14:20,771,868...20,785,549
|
|
| G
|
Syngap1
|
synaptic Ras GTPase activating protein 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of SYNGAP1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr20:5,028,226...5,058,519
Ensembl chr20:5,026,707...5,057,751
|
|
| G
|
Syp
|
synaptophysin
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of SYP mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr X:17,521,348...17,536,449
Ensembl chr X:17,521,348...17,536,984
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of TGFB1 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Thrb
|
thyroid hormone receptor beta
|
affects binding multiple interactions
|
ISO
|
procymidone binds to THRB protein procymidone binds to and results in increased activity of THRB protein
|
CTD |
PMID:28973306 PMID:33049310 |
|
NCBI chr15:10,115,954...10,465,231
Ensembl chr15:10,115,954...10,313,680
|
|
| G
|
Tjp1
|
tight junction protein 1
|
decreases expression
|
ISO
|
procymidone results in decreased expression of TJP1 mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:128,260,330...128,505,158
|
|
| G
|
Tnf
|
tumor necrosis factor
|
increases expression
|
ISO
|
procymidone results in increased expression of TNF mRNA
|
CTD |
PMID:36764477 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tp53bp1
|
tumor protein p53 binding protein 1
|
multiple interactions
|
ISO
|
[procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin co-treated with 4-hydroxy-2-nonenal] affects the expression of TP53BP1 protein; [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] affects the expression of TP53BP1 protein
|
CTD |
PMID:34503147 |
|
NCBI chr 3:128,620,320...128,724,716
Ensembl chr 3:128,620,322...128,696,747
|
|
| G
|
Traf2
|
Tnf receptor-associated factor 2
|
increases expression
|
ISO
|
procymidone results in increased expression of TRAF2 mRNA
|
CTD |
PMID:35913088 |
|
NCBI chr 3:28,740,098...28,764,752
Ensembl chr 3:28,740,098...28,764,691
|
|
| G
|
Tsc2
|
TSC complex subunit 2
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of TSC2 mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr10:14,125,679...14,160,317
Ensembl chr10:14,125,680...14,160,600
|
|
| G
|
Tspo
|
translocator protein
|
decreases expression
|
EXP
|
procymidone results in decreased expression of TSPO mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 7:116,600,214...116,610,461
Ensembl chr 7:116,600,210...116,610,460
|
|
| G
|
Tuba1a
|
tubulin, alpha 1A
|
increases expression
|
EXP
|
procymidone results in increased expression of TUBA1A mRNA
|
CTD |
PMID:15686871 |
|
NCBI chr 7:131,992,151...131,996,850
Ensembl chr 7:131,968,770...131,996,035
|
|
| G
|
Unc5b
|
unc-5 netrin receptor B
|
multiple interactions
|
EXP
|
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of UNC5B mRNA
|
CTD |
PMID:25607892 |
|
NCBI chr20:29,240,639...29,307,270
Ensembl chr20:29,240,650...29,307,270
|
|
| G
|
Xbp1
|
X-box binding protein 1
|
increases expression
|
ISO
|
procymidone results in increased expression of XBP1 mRNA
|
CTD |
PMID:35913088 |
|
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706
|
|
| G
|
Zc3h4
|
zinc finger CCCH-type containing 4
|
decreases expression
|
ISO
|
procymidone results in decreased expression of ZC3H4 mRNA; procymidone results in decreased expression of ZC3H4 mRNA alternative form
|
CTD |
PMID:35913088 |
|
NCBI chr 1:86,234,457...86,271,963
Ensembl chr 1:86,234,457...86,271,963
|
|